AIGEN Sciences
Healthcare & Life Sciences
Recent Finacing
Equity
Recent Raise
$8.8M
AIGEN Sciences is an AI-driven company that develops small-molecule synthetic drugs for diseases with high unmet medical needs.
Focus Areas
AI-driven
drug development
small-molecule
synthetic drugs
unmet medical needs
proprietary platform
Investors
